Timsit-Berthier M, Mautanus H, Poucclet H, Maussiaux P, Legros JJ., Contingent negative variation as a new method to assess the catecholaminergic systems. In: Gallai V, editor. Maturation of the CNS and evoked potentials. Amsterdam: Elsevier, 1986: 260-7
Schoenen J, Maertens de Noordhout A, Timsit-Berthier M, Timsit M., Contingent negative variation (CNV) as a diagnostic and physiopathologic tool in headache patients. In: Clifford Rose F, editor. Migraine: Clinical and Research Advances. Karger: Basel, 1985: 17-25
Kropp P, Gerber WD., Is increased amplitude of contingent negative variation in migraine due to cortical hyperactivity or to reduced habituation? Cephalalgia 1993; 13: 37-41
Maertens de Noordhout A, Timsit-Berthier M, Timsit M, Schoenen J., Effects of beta-blockade on contingent negative variation in migraine. Ann Neurol 1987; 21: 111-12
Schoenen J., Clinical neurophysiology studies in headache: a review of data and pathophysiological hints. Funct Neurol 1992; 7: 191-204
Schoenen J, Wang W, Albert A, Delwaide PJ., Potentiation instead of habituation characterises visual evoked potentials in migraine patients between attacks. Eur J Neurol 1995; 2: 115-22
Áfra J, Proietti-Cecchini A, De Pasque U, Schoenen J., Visual evoked potentials during long duration stimulation in migraine patients between attacks (Abstract). Headache 1996; 36: 261
Mesulam MM., Large-scale neurocognitive networks and distributed processing for attention, language and memory. Ann Neurol 1990; 28: 597-613
Hegerl U, Juckel G., Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 1993; 33: 173-87
Wang W, Timsit-Berthier M, Schoenen J., Intensity dependence of auditory evoked potentials in migraine: an indication of cortical potentiation and low serotonergic neurotransmission. Neurology 1996; 46: 1404-9
Pascual J, del Arco C, Romon T, del Olmo E, Castro E, Pazos A., Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain. Cephalalgia 1996; 16: 317-22
Ferrari MD., Biochemistry of migraine. Pathol Biol 1992; 40: 284-92
Proietti-Cecchini AP, Áfra J, Schoenen J., 311C90, a 5-HT1B/1D agonist, is able to modify central serotonergic neurotransmission in man: evidence from a study of the intensity dependence of the cortical auditory evoked potential 1997; in press
Mitsikostas DD, Papadopoulou-Daifotis, Sifkakis A, Varanos D., The effect of sumatriptan on brain monoamines in rats. Headache 1996; 36: 29-31
Hay KM, Mortimer MJ, Barker DC, Debney LM, Good PA., 1044 women with migraine: the effect of environmental stimuli. Headache 1994; 34: 166-8
Marcus DA, Soso MJ., Migraine and stripe induced visual discomfort. Arch Neurol 1989; 46: 1129-32
Maertens de Noordhout A, Timsit-Berthier M, Timsit M, Schoenen J., Effects of beta-blockade on contingent negative variation in migraine. Ann Neurol 1987; 21: 111-12
Hegerl U, Juckel G., Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 1993; 33: 173-87
Knott JR, Irwin DA., Anxiety, stress and contingent negative variation. Arch Gen Psychiatry 1973; 29: 538-41
